![Brenda Cooperstone](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brenda Cooperstone
Directeur/Membre du Conseil chez
LEXEO THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Brenda Cooperstone is currently an Independent Director at Senti Biosciences Holdings, Inc. since 2026, Director at Senti Sub I, Inc. since 2019, Independent Director at Lexeo Therapeutics, Inc. since 2023, Independent Director at Senti Biosciences, Inc. since 2019, and Independent Director at Gandeeva Therapeutics, Inc. since 2023.
Formerly, Dr. Cooperstone was Chief Development Officer & Senior Vice President at Pfizer Inc. from 2017 to 2022.
Dr. Cooperstone earned a doctorate from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
-.--% | 27/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 15/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Brenda Cooperstone
| Sociétés | Poste | Début |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/08/2023 |
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Directeur/Membre du Conseil | 01/10/2019 |
Senti Biosciences, Inc.
 Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Directeur/Membre du Conseil | 01/10/2019 |
Gandeeva Therapeutics, Inc.
 Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a precision biotechnology company that develops therapeutics | Directeur/Membre du Conseil | 23/01/2023 |
Anciens postes connus de Brenda Cooperstone
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/12/2022 |
Formation de Brenda Cooperstone
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
36
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
Senti Biosciences, Inc.
Senti Biosciences, Inc. BiotechnologyHealth Technology Develops a synthetic biology platform that enables to program next-generation cell and gene therapies | Health Technology |
Gandeeva Therapeutics, Inc.
Gandeeva Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a precision biotechnology company that develops therapeutics | Commercial Services |
